Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “bl-”

8 pharma patents match "bl-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 8
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 8 pharmaceutical patents matching "bl-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

8 results for “bl-” · 30,257 patents in full index Clear search

  1. US 12234230

    Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof

    NURIX THERAPEUTICS, INC. · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  2. US 12187780

    Car t-cells comprising inactivated CBL and CBL-B genes

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  3. US 12049471

    Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof

    NURIX THERAPEUTICS, INC. · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  4. US 12016860

    Combination therapies with Cbl-b inhibitor compounds

    NURIX THERAPEUTICS, INC. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  5. US 11951133

    3-substituted piperidine compounds for Cbl-b inhibition, and use thereof

    NURIX THERAPEUTICS, INC. · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  6. US 11530229

    Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof

    NURIX THERAPEUTICS, INC. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  7. US 11464802

    3-substituted piperidine compounds for Cbl-b inhibition, and use thereof

    NURIX THERAPEUTICS, INC. · Granted Oct 11, 2022 · Expires Oct 6, 2042

    granted
  8. US 11401267

    Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof

    NURIX THERAPEUTICS, INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted